What Is an Independent Accredited Laboratory — and Why Your COA Depends on One

01 Why independence is the starting condition

When a manufacturer tests its own product, it grades its own work. This is not a moral judgment about any particular company; it is a structural observation about incentives. A laboratory that operates within, or under contract exclusively to, the organization that produced the material being tested has no external mechanism to challenge its own methodology, instrument calibration, or interpretation of marginal results.

In regulated sectors — pharmaceutical manufacturing under Good Manufacturing Practice (GMP), food safety under HACCP frameworks, environmental monitoring under government mandates — this problem is resolved by requiring that key analytical decisions be made by parties who have no stake in the outcome. The same logic applies when evaluating a Certificate of Analysis for any research material: the first question is who issued it, and whether that party had any reason to prefer a particular result.

A laboratory qualifies as genuinely independent when it receives samples from a client, applies its own standard operating procedures without client direction, and issues results whose content it could not have influenced in advance. The distinction matters practically: a COA from an independent laboratory allows any third party — a researcher, an institution, a downstream regulator — to contact the laboratory and request raw data. A COA from a manufacturer's own quality department cannot be independently verified; it is, by definition, self-referential.

The difference between first-party, second-party, and third-party testing

First-party testing is performed by the manufacturer on its own product. It serves internal quality control and process management purposes. It does not provide independent verification and should never be presented as a COA to a downstream buyer without that limitation being explicit.

Second-party testing involves a customer auditing a supplier, or a commissioning party performing analysis on received materials. It reduces but does not eliminate conflicts of interest, because the second party still has a stake in the quality of the supply chain.

Third-party testing by a genuinely independent laboratory is the only arrangement that removes the conflict structurally. The laboratory has no financial incentive tied to a particular result, and it will test materials from competing manufacturers under identical conditions.

02 What "accredited" actually means — ISO/IEC 17025 in practice

Independence removes the conflict of interest. Accreditation addresses a separate question: whether the laboratory is technically capable of performing the analyses it claims to perform correctly and reproducibly.

The internationally recognized benchmark is ISO/IEC 17025:2017, published jointly by the International Organization for Standardization and the International Electrotechnical Commission (the full standard is catalogued at iso.org). This is the global standard for competence in testing and calibration laboratories, recognized by regulatory bodies and accreditation networks across more than ninety countries.

The standard imposes requirements across two interconnected domains. The first is a management system: document control, risk identification, complaint procedures, and continuous improvement processes. The second domain — and the one of primary analytical importance — is technical competence. Under this heading, the laboratory must demonstrate:

• Documented and validated analytical methods, with evidence that each method performs as claimed under defined conditions
• Calibrated instruments with traceability to national or international measurement references
• Defined procedures for sample receipt, identification, preparation, and storage — the chain of custody within the laboratory
• An impartiality policy identifying and managing any conflicts of interest
• Qualified analysts with documented competence for each accredited method
• Environmental conditions (temperature, humidity, contamination control) that are monitored and recorded

Crucially, ISO/IEC 17025 accreditation is not self-declared. It is granted only after an on-site technical assessment by qualified assessors from the national accreditation body, followed by regular surveillance visits, and is renewed on a defined cycle — typically every four to five years in most jurisdictions, with interim monitoring.

03 The international accreditation network — where accreditation is recognized

No single global body issues ISO/IEC 17025 accreditation. Instead, a network of national accreditation bodies operates under the International Laboratory Accreditation Cooperation (ILAC) Mutual Recognition Arrangement (MRA). Under the ILAC MRA, accreditation granted by any signatory body is formally recognized by all other signatories. The full list of MRA signatories is published at ilac.org. The principal bodies relevant to research peptide supply chains include:

A COA issued by a laboratory accredited under any ILAC MRA signatory body carries the same formal standing as one issued under any other. This makes it straightforward to evaluate a certificate from a laboratory in a different jurisdiction: find the relevant national body in the ILAC list, search that body's public register, and confirm accreditation status.

04 How to verify a laboratory's accreditation — a step-by-step method

Verification of a laboratory's accreditation status requires three things: the accreditation number from the COA, access to the relevant national body's public register, and knowledge of what to look for in the scope document. This process typically takes under five minutes.

1. Locate the accreditation number on the COA A genuine accredited laboratory will display its accreditation body's logo and a unique accreditation number in the header of every certificate it issues. If a certificate bears no accreditation number and no national body logo, the issuer may not hold formal accreditation.
2. Identify the correct national accreditation body Match the laboratory's country of operation to the corresponding ILAC MRA signatory. If the laboratory is in Germany, that is DAkkS. If in the UK, that is UKAS. If in the United States, it may be A2LA or NVLAP. Use the ILAC website to confirm the correct body for any other country.
3. Search the public register Each national body maintains a publicly searchable online database of accredited laboratories. Enter the laboratory name or accreditation number. The result will confirm whether accreditation is current, suspended, or lapsed, and will link to the scope document.
4. Check that the scope covers the relevant methods Accreditation is method-specific. A laboratory may hold ISO/IEC 17025 accreditation for food chemistry, environmental water testing, or construction materials — and still lack accredited status for HPLC purity of synthetic peptides or LC-MS identity confirmation. The scope document lists each accredited method explicitly. Only accreditation within the relevant analytical scope provides meaningful assurance for a peptide COA.
5. Check that accreditation covers the correct date Accreditation can lapse, be suspended, or be curtailed between surveillance cycles. Confirm that the laboratory held active accreditation on the date the certificate was issued, not merely at some point in the past or present.

05 Scope of accreditation — why the details inside the certificate matter

This is the point most commonly overlooked when reviewing a COA. The phrase "ISO/IEC 17025 accredited laboratory" on a letterhead does not automatically mean that every analytical result on the certificate falls within the accredited scope. A laboratory might hold accreditation for a wide range of food safety parameters while conducting peptide HPLC analysis under an in-house validated but non-accredited method. The result may be technically sound, but it lacks the independent verification layer that accreditation provides.

The Schedule of Accreditation (the scope document) describes each method by type: the analytical technique, the category of sample matrix, and often the measurement range or detection limit. For peptide-related COA verification, the methods of interest are:

• HPLC (High-Performance Liquid Chromatography) for purity determination by percentage peak area
• LC-MS (Liquid Chromatography with Mass Spectrometry) for molecular identity confirmation by measured mass
• Karl Fischer titration for water content determination
• LAL (Limulus Amebocyte Lysate) assay for endotoxin quantification

Any one of these methods appearing on a COA is a statement that the laboratory performed that specific test. The accreditation scope determines whether that test was performed under a formally audited, externally validated protocol.

06 What a COA from an independent accredited laboratory looks like

An issued document from a genuinely independent accredited laboratory follows a consistent anatomy. The laboratory's name, full street address, and contact details appear in the header — not just a web address. The accreditation body's logo and the accreditation number are visible, typically with a statement of the standard (ISO/IEC 17025). A sample receipt date and analytical completion date bracket the chain of custody. The compound name and lot number provided by the submitting client are explicitly stated, making the document traceable to one specific batch and no other. Each analytical result references a named method standard — for example, "HPLC-UV measured according to USP General Chapter <621>" or "LC-MS, validated in-house method ref. XY-003." A named analyst signs or stamps the final page, taking professional responsibility for the data. And the document often carries a statement about result applicability — the scope of what the analysis does and does not confirm.

In contrast, a certificate that bears only a manufacturer's letterhead, reports a purity percentage without a named method or chromatogram, omits an accreditation number, and is signed generically by "Quality Assurance Department" has none of the formal structure that makes a COA independently verifiable.

07 Regulatory context for research peptides

Research peptides — synthetic peptides produced for non-clinical research applications and not authorized as finished medicinal products in a given jurisdiction — occupy a distinct regulatory category whose parameters vary by country. Understanding this context is important when evaluating the significance of a COA.

The European Medicines Agency (EMA) publishes scientific guidelines on quality specifications and testing standards for reference materials used in pharmaceutical contexts. These guidelines (accessible at ema.europa.eu) consistently reference ISO/IEC 17025 accredited laboratories as the evidentiary standard for identity and purity claims that support regulatory submissions. While EMA guidelines are directed at authorized medicines, the technical standards they reference — including the requirement for independent third-party analytical verification — represent the quality framework against which any serious analytical claim is assessed.

The World Health Organization addresses laboratory quality requirements for reference materials and testing through its Technical Report Series and Expert Committee on Biological Standardization. WHO publications (available at who.int) apply the same ISO/IEC 17025 framework as the baseline competence standard for analytical results used to support quality claims in the medicines supply chain.

The United States Pharmacopeia (USP) General Information and Analytical chapters (usp.org) define reference method specifications for chromatographic purity testing that are widely adopted by analytical laboratories as the comparative standard for HPLC and LC-MS methodology. A COA that references USP methods provides a traceable technical basis for its analytical claims, provided the laboratory that applied those methods is independently accredited.

It is essential to understand that laboratory accreditation and regulatory authorization are separate categories. A compound may have a COA from the most rigorously accredited laboratory in the world; that document says nothing about the legal status of the substance in any jurisdiction, and it does not authorize any use. Research peptides that are not approved as medicines are subject to jurisdiction-specific regulations governing research chemicals, and compliance with those regulations is the responsibility of the researcher and their institution — not something a COA confirms or confers.

08 Red flags that suggest a laboratory is not independent or not genuinely accredited

Several observable features indicate that a laboratory may not meet the dual standard of independence and accreditation:

• The laboratory address on the COA is the same as, or in the same facility as, the manufacturer's production site
• No accreditation number appears on the certificate, or the number cannot be located in any national body's public register
• The accreditation body named on the certificate is not an ILAC MRA signatory
• The scope document for the accreditation number retrieved from the register does not include HPLC or LC-MS for synthetic compounds
• The certificate is signed by the manufacturer's own quality team rather than a named analyst at a named third-party laboratory
• The same certificate (same lot number, same date) is reused across different batches or multiple products
• No sample receipt date is recorded, making chain of custody verification impossible

Any one of these flags means the COA cannot be treated as independently verified, regardless of what the purity numbers say. The numbers may be accurate — but accuracy without auditability is not the same as verification.